Skip to content
Erfan Bashar

Inclusion Body Myositis

~2 min read
Last medically reviewed:
On this pageTable of contents

Educational scope notice: This is a study note for medical students, not medical advice, diagnosis, or treatment guidance. Clinical management should follow local protocols and current guidelines.

Inclusion body myositis is the commonest acquired myopathy after age 60 and the one most likely to be mistreated. Its biopsy shows inflammation, so instinct reaches for steroids, yet trial after trial has failed. The disease behaves as a degenerative protein-aggregation disorder with secondary inflammation, closer in spirit to neurodegeneration than to autoimmunity, and recognising it saves the patient from useless immunosuppression.

A distribution unlike the others

Onset is slow and insidious past age 50, with male predominance reversing the female pattern of dermatomyositis and polymyositis. Weakness splits by limb: distal in the arms, where deep finger flexors fail early and grip, jars, and keys become difficult, and proximal in the legs, where quadriceps failure buckles the knees on stairs and chairs. Early asymmetry is common rather than alarming. Dysphagia is frequent and often severe, sometimes the presenting symptom, and it drives much of the morbidity through aspiration.

FeatureInclusion body myositisDermatomyositis and polymyositis
OnsetOver 50 yearsAny age or middle adulthood
DistributionFinger flexors plus quadricepsProximal, symmetric
SymmetryOften asymmetric earlySymmetric
CKNormal or mildly raisedMarkedly raised
Steroid responseNoneGood

An older adult dropping objects and buckling at the knees, unimproved by prednisone, points here through the finger flexors.

What the biopsy shows

Light microscopy finds rimmed vacuoles with granular inclusions that stain red on trichrome, alongside endomysial inflammation milder than polymyositis and grouped atrophic fibres suggesting a neurogenic accent. Electron microscopy reveals tubulofilamentous inclusions in cytoplasm and nucleus, with accumulated beta-amyloid, precursor protein, prion protein, and apolipoprotein E. These aggregates mirror Alzheimer pathology closely enough to support the framing of this disease as a proteinopathy of ageing muscle with inflammation in attendance rather than in command.

Hereditary forms exist with autosomal dominant or recessive patterns, rimmed vacuoles without inflammation, and variable Alzheimer-type staining. Absence of inflammation separates them from the sporadic disease on biopsy, and family history separates them at the bedside.

Diagnosis

CK runs normal or mildly raised, itself a clue against polymyositis. Electromyography mixes myopathic small motor units with neurogenic irritability. Imaging can display the selective quadriceps and flexor fatty replacement of advanced disease. Biopsy with rimmed vacuoles confirms, with electron microscopy settling doubtful cases.

Management and course

No disease-modifying therapy exists. Steroids, antimetabolites, ciclosporin, and immunoglobulin have not altered the course, so care is supportive and practical: physiotherapy for mobility and quadriceps function, occupational adaptations for grip failure, videofluoroscopic swallowing assessment with escalation to myotomy or feeding tube when aspiration threatens, speech therapy for bulbar symptoms, and walking aids against quadriceps-driven falls. Progression spans years to decades toward assisted ambulation, respiratory involvement stays less prominent than in polymyositis, and severe dysphagia with aspiration pneumonia sets much of the prognosis.

Evidence anchors

  • Dalakas MC. Inflammatory muscle diseases. N Engl J Med. 2015;372(18):1734-1747. doi:10.1056/NEJMra1402225
Suggest a correction